Phase 1 trial of gavocabtagene autoleucel (gavo-cel, TC-210) in patients (pts) with treatment refractory mesothelioma and other mesothelin-expressing solid tumors Meeting Abstract
| Authors: | Hassan, R.; Butler, M. O.; Oh, D. Y.; O'Cearbhaill, R. E.; MacMullen, L.; Jeter, E.; Guha, U.; Muzithras, V. P.; Zikaras, K.; Johnson, M. L.; Tanyi, J. L.; Ghafoor, A.; Tighe, R.; Smalley, M.; Quintas-Cardama, A.; Hong, D. S. |
| Abstract Title: | Phase 1 trial of gavocabtagene autoleucel (gavo-cel, TC-210) in patients (pts) with treatment refractory mesothelioma and other mesothelin-expressing solid tumors |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.8537 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 8537 -- Meeting also presented virtually -- Source: Cinahl |
